Stiftung Tierärztliche Hochschule Hannover (TiHo)

Broadly protective influenza vaccines: design and production platforms

Elbahesh, Husni ORCID; Saletti, Giulietta VIAF; Gerlach, Thomas; Rimmelzwaan, Guus F. GND

Effective vaccines are the cornerstone of our defenses against acute influenza virus infections that result in ∼500 000 annual deaths worldwide. For decades, an on-going concerted effort has been to develop a universal influenza vaccine to combat the looming threat of potentially pandemic emerging and re-emerging influenza viruses. To address the need for rapid efficacious vaccines that could mitigate the impact of seasonal and future pandemics, multiple platforms are under development and/or investigation. What is clear is that any universal vaccine must provide long-lasting cross-protective immunity that can induce both B and T cell responses. This review will explore some of the universal influenza vaccine platforms in the contexts of their ability to induce long-lasting and cross-protective T cell immunity.

Cite

Citation style:
Elbahesh, H., Saletti, G., Gerlach, T., Rimmelzwaan, G.F., 2019. Broadly protective influenza vaccines: design and production platforms. Current opinion in virology 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
Could not load citation form. Default citation form is displayed.

Rights

Use and reproduction:
All rights reserved

Export